The CanTest Framework, which provides a conceptual approach for the evaluation of cancer diagnostic tests from development to routine use in primary care, has been published today in BMC Cancer. Developed by the CanTest Senior Faculty team, this new framework addresses some key aspects missing from previous approaches. It incorporates a shift in focus away […]
Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
The continuation of preventive drugs among older patients with advanced cancer is examined in a recent publication in the research journal, Cancer. Dr Stephen Barclay (Department Public Health & Primary Care), collaborated with colleagues from the Karolinska Institute and Newcastle University, finding that the use of preventive drugs in the last year of life is […]
Learning Curve
Cancer Group’s Victoria Hardy reflects on the positives of hosting international exchange students… In February the PCU Cancer Group welcomed two visiting students funded by the SAMRC and Newton Fund via the AWACAN project, working in South Africa and Uganda to improve outcomes for women diagnosed with cervical or breast cancer. PhD student, Amanda Edwards […]
Lung cancer survivors could benefit from check-ups for new cancers for at least ten years
Five-year survival of patients with lung cancer has doubled in England during the past 15 years as lung cancer treatment has become more effective, leading to increasing numbers of survivors. So, optimising surveillance of second primary cancer in this high risk group is becoming increasingly important. Understanding how often such second cancers develop and when […]
‘I thought it was just me’: mutual benefit from public involvement in research
Blog by Dr Anna Spathis, Consultant in Palliative Medicine, Addenbrooke’s Hospital, Associate Specialty Director in Palliative Medicine, School of Clinical Medicine and Dr Stephen Barclay, University Senior Lecturer in Palliative Care, Primary Care Unit, University of Cambridge. Teenage and young adults with cancer have inspired and steered a novel research study to develop a treatment […]
A simple questionnaire could be a cost-effective way to monitor for melanoma skin cancer
Melanoma is rare, but also the most dangerous form of skin cancer, with around 14,500 new cases diagnosed and 2600 deaths in the UK each year. Early detection is critical: overall, around 90 in every 100 patients with melanoma will still be alive five years after diagnosis. But for those diagnosed with advanced disease, only […]